ZRSEF (DocMorris AG) Other Financing: $-123 Mil (TTM As of Jun. 2025)


ZRSEF DocMorris AG ZRSEF
65 GF Score
Price $10.24
GF Value $11.69
! 8 Warning Signs
View Full Analysis

What is DocMorris AG Other Financing?

DocMorris AG ZRSEF 65 Other Financing is $-123 Mil as of Jun. 2025. GuruFocus rates ZRSEF with a GF Score™ of 65/100 and a GF Value™ of $11.69. The stock has 8 warning signs investors should review.

DocMorris AG's Other Financing for the six months ended in Jun. 2025 was $-17 Mil.

DocMorris AG's Other Financing for the trailing twelve months (TTM) ended in Jun. 2025 was $-123 Mil.

DocMorris AG Other Financing Historical Data

* Premium members only.

The historical data trend for DocMorris AG's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocMorris AG Other Financing Chart

DocMorris AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.98 -8.23 -3.17 -234.34 -248.13

DocMorris AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -165.17 -62.37 -141.73 -106.05 -16.55
ZRSEF
65GF Score
DocMorris AG ZRSEF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DocMorris AG Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-123 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-123 Mil mean?
DocMorris AG (ZRSEF) has a Other Financing of $-123 Mil as of Jun. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for DocMorris AG and its competitors.
Is DocMorris AG's Other Financing too high?
DocMorris AG's current Other Financing is $-123 Mil. Overall, DocMorris AG has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Other Financing compare to competitors?
DocMorris AG's Other Financing of $-123 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for DocMorris AG and its competitors. DocMorris AG's current Other Financing is $-123 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
DocMorris AG (ZRSEF) has a current Other Financing of $-123 Mil. The stock's GF Value™ is $11.69, compared to a current price of $10.24 — trading 12.4% below its estimated fair value. The current Other Financing is $-123 Mil. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For DocMorris AG (ZRSEF), the current Other Financing is $-123 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocMorris AG (ZRSEF) Overvalued in 2026?

Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued. The current stock price of $10.24 is trading 12.4% below its estimated GF Value™ of $11.69.

Key valuation signals for ZRSEF:

  • Other Financing: $-123 Mil
  • GF Value™: $11.69 vs. price of $10.24 (12.4% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the ZRSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DocMorris AG Business Description

Address Walzmuhlestrasse 49, Frauenfeld, CHE, 8500
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score

Get the complete analysis for ZRSEF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.24
Price
$11.69
GF Value